Table 3.
Univariate and Cox model analyses of the disease-free survival in the 674 patients.
| Variables | Univariate | Cox model | |
|---|---|---|---|
| p | p | HR [95% CI] | |
| Age (<40 vs. ≥40) | 0.156 | ||
| Sex (Male vs. female) | 0.342 | ||
| Smoker | <0.001 | <0.001 | 1.461 [1.197–1.998] |
| Drinker | 0.471 | ||
| Primary site | |||
| Tongue + The mouth floor vs. others | <0.001 | <0.001 | 2.476 [1.227–3.471] |
| Pathologic tumor stage | |||
| T3+T4 vs. T1+T2 | <0.001 | <0.001 | 3.446 [1.385–6.331] |
| Tumor differentiation | |||
| Moderate + poor vs. well | <0.001 | <0.001 | 1.998 [1.264–3.558] |
| Perineural invasion | <0.001 | <0.001 | 2.363 [1.277–4.338] |
| Lymphovascular invasion | <0.001 | <0.001 | 2.255 [1.304–4.264] |
| Neck lymph node stage | <0.001 | ||
| N0 | |||
| N1 | <0.001 | 1.685 [1.125–2.138] | |
| N2 | <0.001 | 2.453 [1.773–3.467] | |
| N3 | <0.001 | 3.007 [2.162–6.487] | |
| Number of lymph node examined | |||
| <22 vs. ≥22 | 0.267 | ||
| HPV positivity | 0.993 | ||
| p16 positivity | <0.001 | <0.001 | 1.565 [1.183–2.021] |
| Positive margin | <0.001 | <0.001 | 1.996 [1.317–2.778] |
| Number of positive lymph nodes | <0.001 | ||
| 0 | |||
| 1–2 | <0.001 | 1.981 [1.241–2.525] | |
| 3–4 | <0.001 | 3.126 [2.612–4.178] | |
| ≥5 | <0.001 | 5.453 [4.431–8.465] | |